Concepedia

Meilan Liu

ML

Statistics

Publications

28

Citations

2K

H-Index

19

Active since

2004

Affiliations

University of Michigan(Current)

Michigan Center for Translational Pathology

Michigan Medicine

Sun Yat-sen Memorial Hospital

Sun Yat-sen University

Meilan Liu is an author at University of Michigan specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2004–2023

28

Publications

28

PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma

J. Chad Brenner, Felix Y. Feng, Sumin Han et al. · Cancer Research · 2012 · 293 citations · Full text

, , +17

Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer

Corey Speers, Shuang Zhao, Meilan Liu et al. · Clinical Cancer Research · 2015 · 188 citations

, , +17

A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth <i>In Vitro</i> and <i>In Vivo</i>

Fardokht A. Abulwerdi, Chenzhong Liao, Meilan Liu et al. · Molecular Cancer Therapeutics · 2013 · 185 citations · Full text

, , +14

Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa

Yang Meng, Wenhua Tang, Yao Dai et al. · Molecular Cancer Therapeutics · 2008 · 185 citations · Full text

, , +14

Structure-Based Design of Potent, Conformationally Constrained Smac Mimetics

Haiying Sun, Zaneta Nikolovska‐Coleska, Chao‐Yie Yang et al. · Journal of the American Chemical Society · 2004 · 160 citations

, , +9

1–5 of 28